Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
ID: 350132Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350132

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-292.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)." This initiative aims to support research that rigorously assesses barriers to quality cancer treatment and follow-up care for SGM cancer survivors, encouraging proposals for observational and interventional studies that utilize sexual orientation and gender identity (SOGI) data in cancer care settings. The funding is particularly significant as it addresses the unique challenges faced by SGM individuals, including discrimination and healthcare mistrust, with a focus on improving health outcomes for this underserved population. Interested applicants can submit proposals starting January 5, 2024, with a closing date for applications set for January 7, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-292.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-292-Full-Announcement.html
    PAR-23-292.html
    The National Cancer Institute (NCI) has announced a funding opportunity (PAR-23-292) aimed at improving care and outcomes for cancer survivors from sexual and gender minority (SGM) populations. This initiative seeks to address significant barriers to quality cancer treatment faced by SGM individuals, which include discrimination, healthcare mistrust, and gaps in provider knowledge regarding SGM-specific healthcare needs. The NCI encourages proposals for observational and interventional studies utilizing sexual orientation and gender identity (SOGI) data in cancer settings. Applications can address issues such as adherence to treatment, mental health disparities, and the unique challenges faced by SGM cancer survivors. The funding supports projects with a maximum period of five years and emphasizes the integration of community input in research design. Key dates include an application opening on January 5, 2024, with subsequent deadlines for submission and review cycles. Through this funding opportunity, the NCI aims to improve health outcomes for an underserved population, aligning with federal commitments to equity in healthcare access.
    Similar Opportunities
    Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)." This initiative aims to support innovative observational and intervention-based research that identifies and characterizes the pathways and mechanisms contributing to health disparities among sexual and gender minority populations, particularly those from marginalized racial, ethnic, and socioeconomic backgrounds. The research is crucial for addressing evidence gaps related to minority stress, resilience, and culturally responsive healthcare, ultimately promoting equitable health outcomes and improving access to care for these communities. Interested applicants can apply for a maximum funding of $500,000 annually for up to five years, with the application deadline set for January 7, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-077.html.
    The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer," aimed at supporting pilot and exploratory research. This initiative seeks to investigate the combined effects of cancer and HIV stigma on health outcomes for individuals living with HIV who are also diagnosed with cancer, with a focus on developing stigma reduction interventions and promoting research in regions with high burdens of both diseases. The grant, which has a maximum budget of $275,000 for a duration of up to two years, encourages applications from a diverse range of eligible entities, including educational institutions and community organizations. Interested applicants should note that the application period opens on November 13, 2024, and the submission deadline is December 10, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link provided in the announcement.
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Basic Research in Cancer Health Disparities" under the R21 Exploratory/Developmental Research Grant mechanism. This initiative aims to support innovative research investigating the biological and genetic factors contributing to cancer health disparities among various racial and ethnic populations, with a focus on mechanistic studies and the development of new methodologies. The program is designed to foster collaboration among researchers and enhance resources in the field, ultimately leading to a better understanding of cancer disparities. Applications can be submitted starting September 16, 2024, with a budget cap of $275,000 over two years, and the submission deadline is November 16, 2024. For more information, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-291.html.
    The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "The Intersection of Sex and Gender Influences on Health and Disease," inviting R01 applications that explore the impact of sex and gender on health outcomes. This initiative aims to advance the NIH Strategic Plan for Women's Health Research by encouraging research that examines both biological and social factors influencing health and disease, with a focus on addressing health disparities. Eligible applicants include a diverse range of organizations, particularly those that promote inclusivity in research, with funding available up to $350,000 per year for a maximum project period of four years, totaling up to $3 million. Interested parties should submit their applications by November 22, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer," aimed at enhancing research on the intersection of cancer and HIV stigma. This initiative seeks to expand understanding of how these stigmas impact cancer outcomes among HIV-positive individuals, develop interventions to mitigate their negative effects, and promote research in both domestic and international contexts, particularly in regions with high burdens of HIV and cancer. The funding opportunity allows for a maximum project period of five years, with direct costs capped at $500,000 per year, and is open to a diverse range of eligible applicants, including various educational institutions and community organizations. Interested parties must submit their applications by December 10, 2024, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities" (R01, Clinical Trial Required). This initiative aims to solicit applications for projects that identify and address barriers to cancer screening and preventive services, particularly in underserved populations, through multi-level interventions involving patients, clinicians, healthcare settings, and community partners. The focus is on developing evidence-based strategies to improve cancer outcomes for groups such as Black Americans, Hispanics, and Native Americans, emphasizing health equity and structured research methodologies. Interested applicants can find more details and submit proposals by January 7, 2027, with the first application due date being October 5, 2023. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov, and further information is available at NIH Grants.
    Notice of Intent to Publish a Funding Opportunity Announcement for The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at researching the intersection of cancer stigma and HIV stigma in individuals diagnosed with both conditions. This initiative seeks to advance understanding of how these stigmas affect cancer outcomes among HIV-positive individuals, promote stigma reduction interventions, and encourage research in areas with high HIV-cancer burdens. The NIH plans to award up to six R01 grants, each with a ceiling of $500,000, as part of a total estimated funding pool of $5 million, with the NOFO expected to be published in late Summer 2024 and applications due in late Fall 2024. Interested applicants are encouraged to prepare by reviewing related presentations and materials available online.
    Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers" through the R01 Clinical Trial Optional grant mechanism. This initiative aims to support multi-level intervention studies that address both individual and systemic barriers faced by survivors transitioning from pediatric to adult healthcare, with a focus on developing effective strategies for high-quality transitional care. A total funding amount of $10 million is available for fiscal years 2025 and 2026, with up to 12 awards anticipated, and applications are due by October 12, 2024. Interested applicants can find more information and guidelines in the full announcement available at https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-027.html, and inquiries can be directed to grantsinfo@nih.gov.
    Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)" aimed at supporting collaborative research projects that address the long-term adverse effects of cancer therapies. The initiative seeks to identify and characterize the mechanisms behind therapy-induced adverse sequelae, with a focus on developing therapeutic strategies to prevent or mitigate these chronic comorbidities. This funding opportunity is crucial for enhancing patient quality of life through effective interventions based on mechanistic insights and clinical findings. Interested applicants, including various educational and community organizations, must submit their proposals by November 5, 2024, and can find additional information at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)" aimed at supporting exploratory research on the biological and immunological impacts of medical interventions for transgender individuals. This initiative seeks to address critical gaps in understanding how gender reassignment procedures, including hormone therapy and surgeries, affect susceptibility to HIV and other sexually transmitted infections (STIs), particularly in light of the health disparities faced by this population. Eligible applicants include a wide range of institutions such as higher education, nonprofits, and government entities, with a funding ceiling of $275,000 available over a two-year period. Interested parties must submit their applications by December 7, 2024, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.